BioSpace News Archive

AdaptHealth Corp., a leading provider of home medical equipment, supplies and related services in the United States, announced that it will release its financial results for the third quarter ended September 30, 2020, before the opening of the financial markets on Wednesday, November 4, 2020.

Edwards Lifesciences reported financial results for the quarter ended September 30, 2020.

Align Technology, Inc. reported financial results for the third quarter of 2020. Q3’20 total revenues were $734.1 million, up 20.9% year-over-year.

New COVID-19 case projections and county-level test positivity data released by PolicyLab at Children’s Hospital of Philadelphia forecast a continued deteriorating situation throughout the Midwest and Mountain States, raising greater concern for major cities such as Chicago, Indianapolis and Denver.

Allakos Inc. (Nasdaq: ALLK), a biotechnology company developing lirentelimab (AK002) for the treatment of eosinophil and mast cell-related diseases, today announced the publication of results from the multicenter, randomized, double-blind, placebo-controlled Phase 2 study of lirentelimab (AK002) in patients with eosinophilic gastritis and/or eosinophilic duodenitis (ENIGMA) in the New England Journal of Medicine (NEJM). All AK002 dose a

First patient receives ImmunityBio’s second-generation hAd5 COVID vaccine, delivering both outer S (spike) protein and inner N (nucleocapsid) leading to potential long-term T cell and antibody immunity to the SARS-CoV-2 virus

Encouraging clinical results from TACTI-002 and INSIGHT-004 trials of eftilagimod alpha completed recruitment for Stage 1 of Part B in TACTI-002 Study Granted United States patent relating to eftilagimod alpha and LAG525

Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) (“Genomma Lab” or “the Company”), today announced its results for the third quarter ended September 30, 2020 . All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with International Financial Reporting Standards (IFRS). The fo

The rapid increase in lifestyle ailments, rising expenses of healthcare, and increasing number of elderly population have incited various medical insurance organizations and healthcare sector to innovate.

The growing need for minimizing errors and convenience in clinical medication and adequate knowledge of prescribed dose is likely to bolster growth of the global polymer-based prefilled syringe market in the years to come.